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Abstract
Background
Clinical practice guidelines support an early invasive approach after NSTE-ACS in patients
with chronic kidney disease (CKD). There is no direct randomised controlled trial evidence
in the CKD population, and whether the benefit of an early invasive approach is maintained
across the spectrum of severity of CKD remains controversial.
Methods
We conducted a systematic review to evaluate the association between an early invasive
approach and all-cause mortality in patients with CKD. We searched MEDLINE and
EMBASE (1990-May 2015) and article reference lists. Data describing study design, partici-
pants, invasive management strategies, renal function, all-cause mortality and risk of bias
were extracted.
Results
3,861 potentially relevant studies were identified. Ten studies, representing data on
147,908 individuals with NSTE-ACSmet the inclusion criteria. Qualitative heterogeneity in
the definitions of early invasive approach, comparison groups and renal dysfunction
existed. Meta-analysis of the RCT derived and observational data were generally support-
ive of an early invasive approach in CKD (RR0.76 (95% CI 0.49–1.17) and RR0.50 (95%CI
0.42–0.59) respectively). Meta-analysis of the observational studies demonstrated a large
degree of heterogeneity (I2 79%) driven in part by study size and heterogeneity across vari-
ous kidney function levels.
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Conclusions
The observational data support that an early invasive approach after NSTE-ACS confers a
survival benefit in those with early-moderate CKD. Local opportunities for quality improve-
ment should be sought. Those with severe CKD and the dialysis population are high risk
and under-studied. Novel and inclusive approaches for CKD and dialysis patients in cardio-
vascular clinical trials are needed.
Introduction
In non ST elevation acute coronary syndrome (NSTE-ACS) an early invasive approach (coro-
nary angiography followed by revascularisation if appropriate) is the recommended strategy in
patients with hemodynamic instability, refractory angina, electrical instability, or an elevated
risk for clinical events [1]. Although patients with chronic kidney disease (CKD) are recognised
as high risk for poor outcomes after NSTE-ACS, analyses of real world cohorts have consis-
tently suggested that they are less likely to undergo angiography or revascularisation than those
with normal kidney function [2–4]. The reasons behind these practice patterns are complex.
Studies have reported under-estimation of risk, despite paradoxically high GRACE scores [3].
Additionally concerns regarding risk of acute kidney injury (AKI) or a perceived excess bleed-
ing risk are likely to contribute. Practice patterns may also reflect underlying uncertainty as to
whether the overall survival benefit conferred by an early invasive strategy compared with a
selective strategy is maintained across the spectrum of CKD.
There is no direct randomised controlled trial (RCT) evidence available and CKD patients
have historically being under-represented in the relevant clinical trials [5]. A prior meta-analysis
of from five major cardiac trials (n = 1,453) that had collected renal data reported that an early
invasive strategy was associated with non-significant reductions in all-cause mortality in those
with CKD stage 3–5 (eGFR<60ml/minute/1.73m2) [6]. However, whether the results are general-
izable to contemporary non trial CKD patients, in particular those with severe CKD, is not known.
The overall prevalence of CKDwas relatively low at 19% compared with 30–40% reported in regis-
try based analyses [4, 7] and despite pooling data from several clinical trials, the power of the anal-
ysis was limited. 267 participants had CKD stage 4/5 and no data was available on outcomes in
dialysis patients. The most recent trial included was published in 2005 and in the decade since
management of both CKD and ACS have evolved. Although the meta-analysis is supportive of an
early, routine invasive approach in CKD patients with NSTE-ACS the evidence is not definitive.
In the absence of direct RCT data, several observational studies using real world NSTE-ACS
populations have been published. No rigorous systematic review exists to evaluate the quality of
the evidence and summarise the additional data they provide on this important clinical question.
This review sought to assess systematically the published observational evidence to evaluate
whether an early invasive strategy compared with an initial conservative strategy after
NSTE-ACS is associated with an improvement in survival in patients across the spectrum of
CKD.
Subjects and Methods
Types of Studies/Participants
Studies comparing a routine early invasive strategy with a conservative strategy after
NSTE-ACS or unstable angina (UA) in adults (aged>18 years) with CKD.
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Types of Interventions
The management strategies compared were:
1. An early invasive approach with coronary angiography +/- revascularisation if appropriate
2. An initial conservative approach where coronary angiography +/- revascularisation was not
routinely undertaken and patients were managed with a non-invasive strategy initially
We anticipated there may be variation in the definitions used within studies. To provide an
inclusive approach in this review we did not specify further the definitions of early invasive
approach compared with initial conservative strategy.
Outcome. All-cause mortality.
Search Methods
MEDLINE (1990-19th May 2015) and EMBASE (1990-19th May 2015) were searched without
language restrictions or study type restrictions (S1 Appendix). Reference lists were hand-
searched of relevant review articles identified and of the studies included in this systematic
review.
Study Selection
CJS reviewed all the articles identified via the literature search for potential inclusion. The
selection process was undertaken in three stages- first, by reviewing all the identified article
titles; secondly abstracts of relevant articles were reviewed, and finally the full text versions of
selected articles were reviewed. A 10% sample of the publications at each stage was checked by
a second independent reviewer (JBL). Concordance was>80%.
Data Extraction
CJS extracted data from the included studies using pre-designed, piloted extraction forms.
Assessment of Risk of Bias
CJS assessed risk of bias using the Cochrane Collaboration tool for cohort studies. Domains
evaluated included: selection of participants, comparability of study groups and the ascertain-
ment of outcomes of interest and overall risk of bias (S2 Appendix).
For the RCTs within the prior systematic review [6], risk of bias was evaluated in terms of
blinding to outcome assessment, intention to treat analysis for the primary analysis and losses
to follow-up.
Data Synthesis and Statistical Analysis
A narrative synthesis is provided. Summary statistics for the included studies are provided. For
studies that reported an effect estimate and standard error or confidence intervals results were
meta-analysed, stratified by whether the study was an RCT or observational. Meta-regression
was undertaken to explore the effect of study size on heterogeneity between the studies. All
analyses were conducted using STATA v12. This study was reported using PRSIMA guidelines
(S3 Appendix).
Results
The search strategy identified 3,861 unique citations (Fig 1). Ten studies met the inclusion cri-
teria and were included in the review [3, 4, 6, 8–14] (Tables 1 and 2).
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Nine of the included studies were retrospective cohort studies using data from national or
regional level registries (Table 1) [3, 4, 8–14]. The remaining study was the individual level
meta-analysis of five RCTs conducted by Charytan et al [6].
Fig 1. Flow chart showing exclusion process during the literature review. *non relevant systematic or non-
systematic review **non relevant study protocol-wrong exposure. Abbreviations: NSTE-ACS: non ST elevation acute
coronary syndrome; UA: unstable angina.
doi:10.1371/journal.pone.0153478.g001
Early Invasive Strategy versus Conservative Strategy for NSTE-ACS in CKD: A Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0153478 May 19, 2016 4 / 18
Table 1. Summary of the studies included in the systematic review.
First author
(country) Year of
publication
Data source/
Patient
Population
(years of study)
Exposure and
comparison group
deﬁnitions
Deﬁnition of kidney disease
(type of creatinine based
estimating equation)
Study design and
Risk of Bias
Outcome and main
result
Altahan et al (Israel)
2011
ACSIS registry/
NSTE-ACS
(2004–2008)
In patients with and without
kidney disease 3 groups
were compared:1)Early in-
hospital coronary
angiography (<48 h from
admission) 2) Late in-
hospital coronary
angiography (>48 h from
admission)3) No
angiography performed
eGFR<60ml/minute (eGFR:4
point MDRD)
Retrospective
cohort design using
registry data;
MEDIUM risk of
bias
Primary Outcome: 1
yr all-cause mortality
Result: Early
angiography
compared with no
angiography as IP:
eGFR>60ml/minute:
adj HR 0.34(0.18–
0.65) eGFR<60ml/
minute: adj HR 0.46
(0.31–0.68) Late
angiography
compared with no
angiography as IP:
eGFR>60ml/minute:
adj HR 0.58(0.34–
1.01); eGFR<60ml/
minute: adj HR 0.59
(0.43–0.82)
Bhatt et al (USA)
2004
CRUSADE
registry/
NSTE-ACS
(2000–2002)
In patients with and without
kidney disease 2 groups
were compared: 1)Cardiac
catheterization within 48
hours of hospital
presentation 2)No cardiac
catheterization within 48
hours of hospital
presentation
Creatinine>176.8micromol/L
Crcl<30ml/minute or chronic
renal dialysis (Cockcroft and
Gault))
Retrospective
cohort design using
registry data linked
to a quality
improvement
programme;
MEDIUM risk of
bias
Primary Outcome: in
hosp all-cause
mortality Result:
Cardiac
catheterization
within 48 hours
compared with no
cardiac
catheterization
within ﬁrst 48 hours:
No kidney disease:
adj OR 0.68(0.55–
0.88); Kidney disease:
adj OR 0.58(0.37–
0.90)
Chertow et al (USA)
2004
CCP/NSTE-ACS
(1994–1995)
In patients with kidney
disease who were judged
appropriate for in-patient
angiography 2 groups were
compared **: 1)in patient
angiography (+/
revascularisation) 2)no
inpatient angiography(+/-
revascularisation)
Creatinine 1.5mg/dl
(132micromol/L) and <5mg/dl
(442micromol/L) Patients with
creatinine >5mg/dl or on dialysis
were excluded
Retrospective
cohort design using
data from an
observational study
of treatment
patterns and
outcomes of acute
MI in the elderly;
MEDIUM risk of
bias
Primary Outcome: 1
yr all-cause mortality
Result: In patient
coronary
angiography
compared with no in
patient coronary
angiography in
patients with kidney
disease: adj OR 0.54
(0.49–60)
Charytan et al
(FRISC
II-Scandinavia; TIMI
IIIB US; TACTICS
TIMI 18
international;
ICTUS-Dutch
VINO-Czech
republic) 2011
TIMI IIIB, FRISC
II, TACTICS-TIMI
18, VINO, ICTUS
(1989–2003)
In patients with CKD stage
3–5 2 groups were
compared 1)early invasive
strategy 2)conservative
strategy
eGFR<60ml/minute (eGFR: 4
point MDRD)
Individual level
meta-analysis of
RCT data; LOW risk
of bias
Primary Outcome:
all-cause mortality at
6months-1 year
Result: early
invasive strategy
compared with
conservative
strategy in those
with CKD3-5: adj RR
0.77 (0.49–1.17)
(Continued)
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Table 1. (Continued)
First author
(country) Year of
publication
Data source/
Patient
Population
(years of study)
Exposure and
comparison group
deﬁnitions
Deﬁnition of kidney disease
(type of creatinine based
estimating equation)
Study design and
Risk of Bias
Outcome and main
result
Chu et al (Taiwan) NHIRD (2005–
2008)
In patients with and without
kidney disease 2 groups
were compared: 1)
diagnostic coronary
angiography (with intent to
revascularise) within 72
hours of symptom onset 2)
no diagnostic coronary
angiography within 72
hours of symptom onset
CKD deﬁned using ICD-9 codes
585.4, 585.5, 585.9 without
dialysis or ARF(ICD9 code 584)
6 months prior to admission
Retrospective
cohort design using
data from single
payer National
Health Insurance
program (covers
99.9% of Taiwanese
population):
MEDIUM/HIGH risk
of bias
Primary Outcome:
Major adverse cardiac
events
(cardiovascular death,
MI and stroke)
Result: Kaplan Meier
survival curves
plotted. MACE free
survival was lowest in
those with kidney
disease undergoing
EIS
Goldenberg et al
(Israel, Europe)
2010
EUPHORIC
project/
NSTE-ACS and
UA (2000, 2004,
2005, 2006)
In patients with and without
kidney disease 2 groups
were compared: 1)inpatient
coronary angiography
(+/-revascularisation) 2)no
inpatient angiography(+/-
revascularisation)
eGFR<60ml/minute (eGFR:4
point MDRD)
Retrospective
cohort design using
registry data (from 3
registries ACSIS,
MASCARA and
EHS-ACS: MEDIUM
risk of bias
Primary Outcome:
all-cause mortality–in
hospital Result:
Inpatient coronary
angiography
compared with no
inpatient coronary
angiography:
eGFR60ml/minute:
adj OR 0.45(0.26–
0.78); eGFR<60ml/
minute: adj OR 0.64
(0.41–1.00); P-
interaction (eGFR) =
0.31
James et al
(Canada) 2013
APPROACH/
AKDN
NSTE-ACS and
UA (2004–2009)
Outcomes stratiﬁed by
renal function at time of
presentation with
NSTE-ACS were
presented comparing 2
groups: 1) coronary
angiography within 2 days
of admission with
NSTE-ACS (+/-
revascularisation) within 2)
no coronary angiography
within ﬁrst 2 days
Patients were categorised by
ﬁrst eGFR at admission (within
ﬁrst 2 days) eGFR>/ = 60/
minute eGFR 30-59/minute
eGFR<30/minute (eGFR: CKD
EPI)
Retrospective
cohort design using
linked registry data
(ACS with provincial
administrative
healthcare and
laboratory data):
MEDIUM/LOW risk
of bias
Primary Outcome:
All-cause mortality
(Dec 2009) Result:
Coronary
angiography within 2
days compared with
no coronary
angiography within 2
days: eGFR> = 60/
minute = adj HR 0.74
(0.56–0.99); eGFR
30-59/minute = adj
HR 0.66(0.52–0.85);
eGFR<30/
minute = adj HR 0.55
(0.31–0.91);
(overall = adj HR 0.69
(0.58–0.82); p-
interaction 0.624
Lin et al (Taiwan)
2014
Taiwan ACS full
spectrum registry
(2008–2010)
Outcomes In patients with
renal presentation at time
of presentation with
NSTE-ACS were
presented comparing 2
groups: 1)diagnostic
angiography within
72hours of symptom onset
(with intent to
revascularise) 2)no
diagnostic angiography
within 72 hours of symptom
onset
Patients were categorised by
renal function at time of
admission eGFR>60ml/minute
eGFR<60ml/minute (eGFR:
CKD-EPI)
Retrospective
cohort design using
registry data:
MEDIUM risk of
bias
Primary Outcome: 1
yr mortality
(composite of death,
non-fatal MI and non-
fatal stroke) Result:
Diagnostic
angiography within
72 hours compared
with no diagnostic
angiography within
72 hours:
eGFR<60ml/minute:
adj HR 0.53(0.30–
0.92)
(Continued)
Early Invasive Strategy versus Conservative Strategy for NSTE-ACS in CKD: A Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0153478 May 19, 2016 6 / 18
147,908 individuals presenting between 1989–2010 with NSTE-ACS were included across
the ten studies (Tables 3 and 4). The mean age of individuals in the cohort studies ranged from
63–75 years (Table 3). In the RCTs the mean age of the recruited population was 63 years,
although in those with CKD it was higher (68 years) [6]. Cohort size varied from 57,284 indi-
viduals (CCP) [10] to 834 people (NHIRD) [11]. 60% (n = 87,432) of included participants
were male (9 studies with data available). The prevalence of CKD varied between 10–40%.
Where data on eGFR<30ml/minute/1.73m2 was reported the prevalence ranged from 0.9%
(n = 4) in the FRISC II trial [6, 15] to 9% (n = 3,238) within the MINAP cohort study [4]
Table 1. (Continued)
First author
(country) Year of
publication
Data source/
Patient
Population
(years of study)
Exposure and
comparison group
deﬁnitions
Deﬁnition of kidney disease
(type of creatinine based
estimating equation)
Study design and
Risk of Bias
Outcome and main
result
Shaw et al (UK)
2014
MINAP/
NSTE-ACS
(2008–2010)
Outcomes stratiﬁed by
renal function at time of
presentation with
NSTE-ACS were
presented comparing 2
groups: 1)in hospital
coronary angiography
(+/-revascularisation) 2)no
in-hospital coronary
angiography (or
revascularisation)
Patients were categorised by
renal function at time of
admission: eGFR>90 ml/minute,
eGFR 60–90 ml/minute, eGFR
30–60 ml/minute; eGFR <30 ml/
minute (eGFR: CKD-EPI)
Retrospective
cohort design using
registry data;
MEDIUM risk of
bias
Primary Outcome:
all-cause mortality at
1 year Result: In-
hospital
angiography
compared with no
in-hospital coronary
angiography: eGFR
45-59ml/minute adj
OR 0.37(0.32–0.43);
eGFR 30-44ml/minute
adj OR 0.41(0.34–
0.48); eGFR<30ml/
minute adj OR 0.46
(0.36–0.58); p-
interaction <0.001
Wong et al
(Canada) 2009
ACS1 and ACS2
(1997–2007)
In patients with kidney
disease 2 groups were
compared 1)in hospital
coronary angiography
(+/-revascularisation) 2)no
in-hospital coronary
angiography (or
revascularisation)
Patients were categorised by
renal function: eGFR60ml/
minute; eGFR30-59ml/minute;
eGFR<30ml/minute including
dialysis; (eGFR:4 point MDRD)
Retrospective
cohort design using
registry data;
MEDIUM/HIGH risk
of bias
Primary Outcome: 1
yr all-cause mortality
Result: In-hospital
angiography
compared with no
in-hospital coronary
angiography:
unadjusted 1 year
mortality rates were
lower among patients
receiving in-hospital
coronary angiography
for all levels of kidney
dysfunction
Abbreviations: eGFR: estimated glomerular ﬁltration rate (ml/minute/1.73m2); adj HR: adjusted hazard ratio; adj OR: adjusted odds ratio; adj RR-adjusted
risk ratio; MDRD:Modiﬁed diet in Renal Disease; CKDEPI:Chronic Kidney Disease Epidemiology Collaboration
ACSIS: Acute Coronary Syndromes Israeli Survey; CRUSADE: Can Rapid Risk Stratiﬁcation of Unstable Angina Patients Suppress Adverse Outcomes
With Early Implementation of the ACC/AHA Guidelines; CCP: Cooperative Cardiovascular Project; FRISC II Fragmin and Fast Revascularization during
Instability in Coronary Artery Disease; VINO: Value of ﬁrst day angiography/ angioplasty In evolving Non-ST segment elevation myocardial infarction; TIMI
IIIB: Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial; TACTICS TIMI18: The Treat Angina with Aggrastat and determine Cost of Therapy with
an Invasive or Conservative Strategy; ICTUS: Invasive versus Conservative Treatment in Unstable Coronary Syndromes; NIHRD National Health
Insurance Research Database; EUPHORIC: European Public Health Outcome Research and Indicators Collection Project; APPROACH: Alberta
Provincial Project for Outcome Assessment in Coronary Heart Disease; AKDN: Alberta Kidney Disease Network; MINAP: Myocardial Ischaemia National
Audit Project; ACSI/II: Canadian Acute Coronary Syndromes I and II
* estimated from Fig within published paper
** 92 clinical indicators were used to categorise individuals to an “appropriateness” score for angiography
doi:10.1371/journal.pone.0153478.t001
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(Tables 3 and 4). The prevalence of diabetes varied between 8% (TIMI III) [6, 16]and 41%
(NHIRD) [11](Tables 3 and 4).
Qualitatively there was variation between the studies. There were a range of definitions used
for early invasive strategy (TableS 1 and 2). The RCTs included in the meta-analysis all utilised
similar definitions (Table 2). The most variation was seen in the FRISC II trial defining early
invasive strategy as within the first week [15], compared to within the first 24–48 hours
(Table 2) [6, 16–19]. The cohort studies used three variants of definition (Table 1). The CRU-
SADE and APPROACH analyses used a time frame of initial coronary angiography within the
first 48 hours, compared with those that did not undergo coronary angiography in that time
frame [9, 13]. The ACSIS study used the same early intervention definition but compared out-
comes with those who did not undergo angiography during the index admission [8]. The
NHIRD and Taiwan ACS Full Spectrum studies defined early invasive strategy as within
72 hours [11, 14]. The CCP, EUPHORIC, MINAP and the ACSI/II based studies compared
individuals who underwent inpatient coronary angiography with those that did not (Table 1)
[3, 4, 10, 12].
The definition of CKD varied. All studies defined renal disease using biochemical parame-
ters except the NHIRD (ICD-9 codes on financial claim forms) [11] (Table 1). The CCP,
APPROACH and NHIRD based analyses excluded dialysis patients [10, 11, 13]. In contrast,
ACSI/II and CRUSADE based studies specifically commented that dialysis patients were
included [3, 9]. In ACSI/II they were incorporated into eGFR<30/minute/1.73m2 (N = 639)
and in the CRUSADE study in the binary definition of renal insufficiency used. Several trials
included in the RCT meta-analysis had exclusion criteria equating to moderate to severe CKD
(Table 2)[6]. No data were provided regarding patients with renal transplants.
The trials in the RCT meta-analysis were judged to be low risk of bias [6]. No cohort studies
were judged to be of overall low risk of bias (Table 1 and S2 Appendix). Several studies reported
exclusions to reduce risk of immortal time bias [4, 13]. Processes of validation and quality
assurance were variably reported resulting in several studies being judged at risk of information
Table 2. Characteristics of the randomised controlled trials included in the systematic review by Charytan et al [6].
VINO [17] FRISC II [15] TIMI IIIB [16] TACTICS-TIMI 18 [18] ICTUS [19]
Full study title
(Year of
publication)
Value of ﬁrst day
angiography/
angioplasty In evolving
Non-ST segment
elevation myocardial
infarction(2002)
Fragmin and Fast
Revascularization during
Instability in Coronary
Artery Disease (2001)
Thrombolysis in
Myocardial Infarction
(TIMI) IIIB clinical trial
(1995)
The Treat Angina with
Aggrastat and determine
Cost of Therapy with an
Invasive or Conservative
Strategy (2001)
Invasive versus
Conservative
Treatment in Unstable
Coronary Syndromes
(2005)
Interventions First day angiography
vs. symptom/stress test-
driven angiography
First week angiography vs.
symptom/stress test
driven angiography;
Dalteparin vs. placebo
Angiography within 18–
48 hours vs. symptom/
stress test-driven
angiography; TPA vs.
placebo
Angiography within 4–48
hours vs. symptoms/stress
test driven angiography
Angiography within
24–48 hours vs.
symptom /stress test-
driven angiography
Type of ACS Non-STEMI Non-STEMI and UA Non-Q wave MI and UA Non-STEMI and UA Non-STEMI
Renal
exclusions
NA Creatinine >1.8mg/dl
(>159micromol/L)
Creatinine >3mg/dl
(>265micromol/L)
Creatinine >2.5mg/dl
(>221micromol/L)
NA
Primary end
point (time
point)
Composite of death and
nonfatal MI (6months)
Composite of death and
nonfatal MI (6 months)
Composite of death and
nonfatal MI or
“unsatisfactory” stress
test (6 weeks)
Composite of death and
nonfatal MI and
hospitalisation for acute
coronary syndrome (6
months)
Composite of death
and nonfatal MI or
hospitalisation for
angina (1 year)
Abbreviations: TPA: tissue plasminogen activator; non-STEMI: non ST elevation myocardial infarction; UA: unstable angina; MI: myocardial infarction;
CABG: coronary artery bypass graft; PTCA: percutaneous transluminal coronary angioplasty; CHF: congestive heart failure; NA: not applicable
doi:10.1371/journal.pone.0153478.t002
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bias. The use of single renal function measures across all the studies introduced the risk of
CKD misclassification.
All studies presented multivariable analyses except the NHRID and ACSI/II analyses were
univariable [3, 11]. Common variables adjusted for included age, sex, diabetes and previous
coronary artery disease. Most confounder variables were in binary/categorical format introduc-
ing risk of residual confounding. Potentially important confounders such as ethnicity, socio-
economic status or adjunctive medical therapies were not routinely included (S4 Appendix).
Study Specific Results
All the cohort studies that reported multivariable adjusted results reported a survival benefit asso-
ciated with an early invasive strategy compared to a conservative strategy in those with CKD
(Table 1 and Fig 2) [4, 8–10, 12–14]. Relative benefits of between approximately 30–50% were
reported across the cohort studies (Table 1 and Fig 2). The NHIRD reported unadjusted Kaplan
Meier survival probabilities which suggested that an early invasive strategy in those with CKD
was associated with a poorer survival probability than conservative strategy [11] (Table 1). This
was in contrast to the univariable results presented by the ACSI/II analyses [3] (Table 1).
Where outcomes were stratified by CKD stage there was a suggestion that the survival bene-
fit may be attenuated in those with CKD 4/5- except in the APPROACH study (eGFR<30: adj
HR 0.55 (95% CI 0.31–0.98)[13] (Fig 2). In two studies however the confidence intervals
crossed one, likely reflecting the low numbers of patients within this CKD class in those studies
(EUPHORIC eGFR<30: adj OR 1.31(95% CI 0.58–2.94); Charytan et al eGFR<30: RR 0.78
(0.33–1.82) [6, 12]. The APPROACH and EUPHORIC studies reported no evidence of interac-
tion by eGFR on the association between early invasive strategy and mortality in contrast to
the MINAP report (Table 1 and Fig 2)[4].
Meta-analysis of the RCT derived data across all CKD stages suggested a trend to improved
survival although the 95% confidence interval crossed one (adjusted HR 0.77 (95% CI 0.49–
Table 4. Selected demographic and clinical characteristics of the RCT based populations included in the meta-analysis by Charytan et al [6].
TIMI IIIB
N = 1,473
FRISC II
N = 2,457
TACTICS-TIMI 18
N = 2,220
VINO N = 131 ICTUS N = 1,200
Age, year (mean) 59 66a 62 66 62 a
Men (n,[%]) 972(66) 1,708(70) 1,463(66) 80(61) 880(73)
White ethnicity (n,[%]) 1178(80) NA 1722(78) NA NA
Diabetes (n, [%]) 114(8) 299(12) 613(28) 33(25) 166(14)
Renal dysfunction (n, [%]) eGFR<60 = 449
(30)
eGFR<60 = 429
(17)
eGFR<60 = 429(19) eGFR<60 = 29
(22)
eGFR<60 = 117
(10)
Characteristic in those with eGFR<60ml/minute/1.73m2
N = 449 N = 429 N = 429 N = 29 N = 117
White ethnicity (n, [%]) 403(90) 429(100) 340(79) 29(100) NA
eGFR <30 (n, [%]) 216 (48) 4(0.9) 29(7) 10(3) 8(7)
Diabetes (n, [%]) 39(9) 75(17) 146 (34) 18 (62) 29 (25)
Previous MI (n, ([%]) 188 (42) 146 (34) 188 (44) 15(52) 43(37)
ST-segment changes (n,[%]): 176(39) 237(55) 170 (40) 20 (69) 52 (44)
EIS/ECS (n, [%]) 221/228 (49/51) 211/218(49/51) 216/213(50/50) 12/17(41/59) 58/59(50/50)
Coronary revascularisation during follow-up
(invasive/conservative strategies) (n, [%])
147/144 (66/63) 158/101 (74/46) 123/90 (57/42) 6/7 (50/41) 38/27 (66/45)
EIS: early invasive strategy; ECS: early conservative strategy; eGFR: estimated glomerular ﬁltration rate (ml/minute/1.73m2); MI:myocardial infarction
a median
doi:10.1371/journal.pone.0153478.t004
Early Invasive Strategy versus Conservative Strategy for NSTE-ACS in CKD: A Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0153478 May 19, 2016 10 / 18
Fig 2. Forest plot illustrating study specific effects for the association between an early invasive strategy
andmortality compared with a conservative management strategy with results stratified by estimated
glomerular filtration rate. *the effect estimate presented is for those with an eGFR<60ml/minute/1.73m2 or the
definition of kidney disease used within the specific study. For these studies results stratified further into
subcategories of eGFR/CKD stages were not available. Results from the random effects meta-analysis conducted
by Charytan et al are reported. The overall effect estimate for those with an eGFR<60ml/minute/1.73m2 is reported
and then also results of the analysis further stratified by eGFR category (hollow diamonds). Results from the
APPROACH study were reported overall for eGFR<60ml/minute/1.73m2 and also stratified by eGFR category (p-
interaction by eGFR 0.624). Results from the EUPHORIC study were reported overall for eGFR<60ml/minute/
Early Invasive Strategy versus Conservative Strategy for NSTE-ACS in CKD: A Systematic Review
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1.17)(Fig 3) with an I2statistic of 14%. Meta-analysis of the observational studies also supported
an early invasive strategy however there was marked between study heterogeneity (I2 statistic
79%). After meta-regression for study size this reduced to 64%. Removal of the MINAP study
from the meta-analysis reduced the I2 statistic to 30%.
Meta-analysis restricted to studies which reported data on those with CKD stage 4 or more
(eGFR<30ml/minute) suggested a trend to improves survival with an early invasive strategy
(RR0.63 95% CI 0.41–0.97) (Fig 4). Data were not meta-regressed due to a limited number of
studies contributing to this analysis.
Discussion
Our comprehensive search strategy identified ten studies that reported on the association
between an early invasive strategy after NSTE-ACS and mortality compared with a conserva-
tive strategy in patients with CKD. Despite qualitative heterogeneity between the studies, all of
the cohort studies except one unadjusted analysis reported a survival benefit associated with an
early invasive approach. The meta-analysis of RCT data reported a trend to an improved sur-
vival, although the interpretation is cautiously applied as the confidence interval crossed one.
Our meta-analysis of observational data also supported an early invasive approach in those
with CKD. However whether the survival benefit is maintained in severe renal impairment
(CKD 4 and 5) seems less clear with small sample sizes having limited the power in several of
the studies. There is a lack of data addressing this important clinical question specifically in the
dialysis population.
To the best of our knowledge this is the first systematic review addressing this research
question to incorporate both the available observational evidence from relevant cohort studies
and previous meta-analysis of RCTs. We used a comprehensive search strategy, with broad def-
initions of kidney disease and interventional strategy after NSTE-ACS for a thorough and
inclusive search. We provide a detailed narrative summary with focus on the methodologies of
the included studies. The studies identified represented a large international CKD population
with NSTE-ACS and with the inclusion of several national registry based analyses reflect actual
clinical practice patterns and outcomes in contemporary populations with NSTE-ACS and
CKD.
Meta-analysis of the observational studies demonstrated a large degree of heterogeneity.
Some of this was driven by study size. Additionally, a large proportion of this was driven by the
MINAP based analysis. This study included one of the largest populations, in particular
1.73m2 and also stratified by eGFR category (p-interaction by eGFR 0.31). Results from the MINAP study were
reported stratified by eGFR category (p-interaction by eGFR <0.001). Effect estimates for each of the studies
included in the plot: ACSIS[8]- adjusted hazard ratio; CRUSADE[9]-adjusted odds ratio; APPROACH [13]-adjusted
risk ratio; Charytan et al [6]- risk ratio; Tai (Taiwan ACS full spectrum registry) [14]-adjusted hazard ratio; CCP[10]-
adjusted odds ratio; EUPHORIC [12]- adjusted odds ratio MINAP [4]–adjusted odds ratio. Abbreviations: EIS: early
invasive strategy; ECS: early conservative strategy; ES: effect estimate; 95%CI: 95% confidence interval; TAIWAN
ACS: TAIWAN ACS Full Spectrum Registry; ACSIS: Acute Coronary Syndromes Israeli Survey; CRUSADE: Can
Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse OutcomesWith Early Implementation of the
ACC/AHAGuidelines; CCP: Cooperative Cardiovascular Project; FRISC II Fragmin and Fast Revascularization
during Instability in Coronary Artery Disease; VINO: Value of first day angiography/ angioplasty In evolving Non-ST
segment elevation myocardial infarction; TIMI IIIB: Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial;
TACTICS TIMI18: The Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative
Strategy; ICTUS: Invasive versus Conservative Treatment in Unstable Coronary Syndromes; EUPHORIC:
European Public Health Outcome Research and Indicators Collection Project; APPROACH: Alberta Provincial
Project for Outcome Assessment in Coronary Heart Disease; MINAP: Myocardial Ischaemia National Audit Project.
doi:10.1371/journal.pone.0153478.g002
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including individuals with severe CKD and a high degree of co-morbidity. It was the only
study which reported in its primary analysis evidence of interaction by stage of CKD on the
association between an early invasive approach and mortality. Additionally, observational
Fig 3. Forest plot andmeta-analysis across all stages of kidney function for the association between an early invasive strategy andmortality
compared with a conservative management strategy with results stratified by estimated glomerular filtration rate. Effect estimates for each of the
studies included in the plot: ACSIS[8]- adjusted hazard ratio; CRUSADE[9]-adjusted odds ratio; APPROACH [13]-adjusted risk ratio; Charytan et al [6]-
risk ratio; Tai (Taiwan ACS full spectrum registry) [14]-adjusted hazard ratio; CCP[10]- adjusted odds ratio; EUPHORIC [12]- adjusted odds ratio MINAP
[4]–adjusted odds ratio. Abbreviations: EIS: early invasive strategy; ECS: early conservative strategy; ES: effect estimate; 95% CI: 95% confidence
interval; TAIWAN ACS: TAIWAN ACS Full Spectrum Registry; ACSIS: Acute Coronary Syndromes Israeli Survey; CRUSADE: Can Rapid Risk
Stratification of Unstable Angina Patients Suppress Adverse OutcomesWith Early Implementation of the ACC/AHAGuidelines; CCP: Cooperative
Cardiovascular Project; FRISC II Fragmin and Fast Revascularization during Instability in Coronary Artery Disease; VINO: Value of first day angiography/
angioplasty In evolving Non-ST segment elevation myocardial infarction; TIMI IIIB: Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial;
TACTICS TIMI18: The Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy; ICTUS: Invasive versus
Conservative Treatment in Unstable Coronary Syndromes; EUPHORIC: European Public Health Outcome Research and Indicators Collection Project;
APPROACH: Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease; MINAP: Myocardial Ischaemia National Audit Project.
doi:10.1371/journal.pone.0153478.g003
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studies have recognised limitations in their robustness in evaluating the comparative effective-
ness of interventions [20] and cannot be interpreted as causal. Nevertheless, for the majority of
data, despite the heterogeneity across definitions of various kidney function levels, it is reassur-
ing that the qualitative picture generally supports that an early invasive approach is favoured
when looking at the RCT derived and observational data jointly.
Definitions of early invasive therapy and corresponding comparison group, in particular in
the cohort studies, varied. This reflects the strengths and limitations of utilising existing rou-
tinely collected data sources for research. Often these resources are designed for a different pri-
mary use- for example audit, rather than the research question being addressed. Despite the
large populations included and wide range of information collected, there may be lack of gran-
ularity of information available. Bias can also be introduced. For example, studies comparing
Fig 4. Forest plot andmeta-analysis of studies reporting results in those with an eGFR<30ml/minute/1.73m2 for the association between an early
invasive strategy andmortality compared with a conservative management strategy with results stratified by estimated glomerular filtration rate.
Results from the APPROACH study were reported overall for eGFR<60ml/minute/1.73m2 and also stratified by eGFR category (p-interaction by eGFR
0.624). Results from the EUPHORIC study were reported overall for eGFR<60ml/minute/1.73m2 and also stratified by eGFR category (p-interaction by eGFR
0.31). Results from the MINAP study were reported stratified by eGFR category (p-interaction by eGFR <0.001). Effect estimates for each of the studies
included in the plot: ACSIS[8]- adjusted hazard ratio; CRUSADE[9]-adjusted odds ratio; APPROACH [13]-adjusted risk ratio; Charytan et al [6]- risk ratio; Tai
(Taiwan ACS full spectrum registry) [14]-adjusted hazard ratio; CCP[10]- adjusted odds ratio; EUPHORIC [12]- adjusted odds ratio MINAP [4]–adjusted odds
ratio. Abbreviations: EIS: early invasive strategy; ECS: early conservative strategy; ES: effect estimate; 95% CI: 95% confidence interval; TAIWAN ACS:
TAIWAN ACS Full Spectrum Registry; ACSIS: Acute Coronary Syndromes Israeli Survey; CRUSADE: Can Rapid Risk Stratification of Unstable Angina
Patients Suppress Adverse OutcomesWith Early Implementation of the ACC/AHAGuidelines; CCP: Cooperative Cardiovascular Project; FRISC II Fragmin
and Fast Revascularization during Instability in Coronary Artery Disease; VINO: Value of first day angiography/ angioplasty In evolving Non-ST segment
elevation myocardial infarction; TIMI IIIB: Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial; TACTICS TIMI18: The Treat Angina with Aggrastat
and determine Cost of Therapy with an Invasive or Conservative Strategy; ICTUS: Invasive versus Conservative Treatment in Unstable Coronary
Syndromes; EUPHORIC: European Public Health Outcome Research and Indicators Collection Project; APPROACH: Alberta Provincial Project for Outcome
Assessment in Coronary Heart Disease; MINAP: Myocardial Ischaemia National Audit Project.
doi:10.1371/journal.pone.0153478.g004
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inpatient angiography with no inpatient angiography are at particular risk of immortal time
bias which could result in an overestimate of the survival advantage associated with an early
invasive therapy [4, 10, 12, 21]. The MINAP based report used a sensitivity analyses excluding
people who died early to help evaluate the possible impact of such bias; reassuringly the find-
ings were similar to the main analyses [4, 21]. Careful definition of the cohort so as not to
advantage one group over the other is required. The APPROACH study excluded those who
died within the first two days and then examined the remaining cohort, comparing those who
had coronary angiography within the first two days with those that did not thus removing the
risk of immortal person-time [13].
Other biases may also be important. All nine of the studies that used biochemistry to define
CKD utilised a single measure of renal function to estimate CKD stage with the risk of misclassi-
fication of CKD stage. Several studies specified that the admission measure was utilised. Without
pre-morbid renal function estimates this could result in cases of AKI being categorised as CKD
resulting in an over-estimation of the prevalence of CKD. However, in clinical practice pre-mor-
bid renal function may not be available with clinical decisions being made on the basis of single
measures and it is likely the results reflect actual clinical practice. Linkage of registries to labora-
tory systems or other repositories of longitudinal clinical data may facilitate future research to
understand the relative contributions of CKD and AKI on outcomes [13, 22].
In addition to all-cause mortality, one study reported the risk of AKI and progression to end
stage renal disease (requiring renal replacement therapy[RRT]) associated with early invasive
therapy. In the APPROACH study people who received early invasive management were mod-
estly more likely to develop AKI but the risks of requiring dialysis and long term risk of end
stage renal disease were similar, and patients had better long term survival than those treated
conservatively [13]. These findings were consistent across varying levels of baseline kidney
function, suggesting similar relative risks and benefits of early invasive management in people
with and without pre-existing kidney disease [13]. Although lacking information on AKI/RRT
the MINAP study results also support a survival benefit across the CKD stages however the sta-
tistical homogeneity of effects for early invasive therapy on survival was not observed [4]. This
may reflect differences in the adjustment for confounders between the two studies, or differ-
ences in the included populations. The less conservative effect estimates observed in the
MINAP study and a more parsimonious approach to the propensity score suggest that adjust-
ment for confounding variables may not have been as effective. Statistical tests of interaction
tend to be of low power and this is another possible explanation. The EUPHORIC study and
meta-analysis by Charytan et al reported contrasting effect estimates in association with an
early invasive therapy in those with an eGFR<30ml/minute/1.73m2 but with wide confidence
intervals [6, 12]. Both studies were potentially limited in their stratified analysis by low patient
numbers in this category. Importantly none of the studies reported outcomes specifically in an
ESRF requiring RRT population.
There are limitations to the review. The strategy to utilise a checking process of 10% during
study selection was pragmatic; reassuringly the degree of agreement was high. Data extraction
and evaluation of risk of bias were undertaken by a single person. Steps including piloted data
extraction forms and double checking of data were taken to reduce the potential of error being
introduced. There were five studies which were unavailable in full text/English language [23–
27]. A single abstract of a meta-analysis reporting outcomes after early invasive therapy in dial-
ysis patients was identified. The data were provisionally supportive of an early invasive
approach however no judgement on the quality of the studies utilised could be made-therefore
the data was not included [27]. The other four abstracts did not suggest information pertaining
to CKD was reported but there is a small risk that some relevant data may have been missed.
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Specific data on important outcomes including recurrent myocardial infarction, stent
thrombosis or length of stay were not available. These should be included in future studies.
The evidence from the observational studies in this systematic review generally support that
an early invasive therapy in NSTE-ACS or UA is associated with a survival advantage in
patients with early and moderate CKD. This review adds further support to the current recom-
mendations within clinical guidance [1, 28]. However, there remains a paucity of data relating
to patients with severe CKD and in particular those managed with dialysis or renal transplanta-
tion. Whether an early invasive approach is the preferred approach in these groups remains
less clear. Renal and cardiology communities must work collaboratively on an inclusive
approach to future trials in NSTE-ACS to understand the optimal therapeutic strategies and
improve the outcomes of these high risk, under-studied patient groups.
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